FACULTY
James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan

EDUCATIONAL OBJECTIVES 
At the completion of this activity the participant will be able to: 
  • Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
  • Identify patients who are at high risk for major bleeding secondary to DOAC use
  • Examine current and emerging DOAC reversal agents and their safety and efficacy
  • Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignettes
TARGET AUDIENCE: Health-system pharmacists
ACTIVITY TYPE: Application 
RELEASE DATE: March 15, 2019
EXPIRATION DATE: March 15, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours
FEE: This lesson is offered for free at www.pharmacytimes.org